Hui-Chun Huang Selected Research

Ligation

2/2024	Ezetimibe treatment reduces oxidized low-density lipoprotein in biliary cirrhotic rats.
12/2023	Endoscopic variceal ligation versus propranolol for the primary prevention of oesophageal variceal bleeding in patients with hepatocellular carcinoma: an open-label, two-centre, randomised controlled trial.
9/2023	Synthesis, characterization, and biological verification of asialoglycoprotein receptor-targeted lipopolysaccharide-encapsulated PLGA nanoparticles for the establishment of a liver fibrosis animal model.
1/2023	Dual angiotensin receptor and neprilysin inhibitor reduced portal pressure through peripheral vasodilatation and decreasing systemic arterial pressure in cirrhotic rats.
10/2022	α-Adrenergic blockade prevented environmental temperature reduction-induced transient portal pressure surge in cirrhotic and portal hypertensive rats.
10/2022	Sodium-Glucose Cotransporter-2 Inhibition Exacerbates Hepatic Encephalopathy in Biliary Cirrhotic Rats.
12/2021	Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats.
12/2021	Effects of dipeptidyl peptidase-4 inhibition on portal hypertensive and cirrhotic rats.
11/2021	Matrix metalloproteinase-9 inhibition or deletion attenuates portal hypertension in rodents.
7/2021	Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Chun Huang Research Topics

Disease

51	Fibrosis (Cirrhosis) 02/2024 - 12/2005
38	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 09/2006
35	Portal Hypertension 01/2023 - 02/2002
17	Inflammation (Inflammations) 02/2024 - 07/2010
15	Hepatic Encephalopathy 10/2022 - 03/2005
13	Hemorrhage 12/2023 - 02/2002
10	Acute Liver Failure (Fulminant Hepatic Failure) 11/2016 - 01/2005
8	Brain Diseases (Brain Disorder) 11/2016 - 01/2005
6	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2024 - 09/2006
6	End Stage Liver Disease 01/2024 - 11/2009
6	Hepatopulmonary Syndrome 01/2020 - 04/2013
5	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 08/2006
5	Hypoxia (Hypoxemia) 01/2020 - 09/2015
5	Body Weight (Weight, Body) 11/2018 - 05/2009
5	Hypotension (Low Blood Pressure) 01/2015 - 11/2009
4	Liver Diseases (Liver Disease) 10/2023 - 01/2011
4	Shock 04/2020 - 01/2014
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2019 - 10/2013
4	Parkinson Disease (Parkinson's Disease) 12/2015 - 01/2012
4	Liver Failure 02/2012 - 07/2008
3	COVID-19 11/2023 - 07/2020
3	Heart Failure 01/2021 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2012
3	Sepsis (Septicemia) 04/2020 - 08/2017
3	Pneumonia (Pneumonitis) 01/2020 - 01/2017
3	Critical Illness (Critically Ill) 12/2018 - 12/2014
3	Chronic Hepatitis B 11/2018 - 06/2010
3	Hepatitis 11/2018 - 01/2013
3	Ascites 10/2015 - 07/2011
2	Hyperlipidemias (Hyperlipidemia) 02/2024 - 07/2022
2	Atherosclerosis 02/2024 - 04/2023
2	Bacterial Infections (Bacterial Infection) 01/2024 - 12/2014
2	Clostridium Infections 11/2023 - 09/2022
2	Ventricular Tachycardia 07/2023 - 01/2020
2	Ischemic Stroke 04/2023 - 04/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
2	Hypertension (High Blood Pressure) 01/2022 - 05/2012
2	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2022
2	Chronic Hepatitis C 01/2021 - 01/2020
2	Septic Shock (Toxic Shock Syndrome) 04/2020 - 08/2017
2	Mental Disorders (Mental Disorder) 02/2019 - 09/2007
2	Stroke (Strokes) 01/2019 - 12/2016
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2018 - 01/2014
2	Endotoxemia 11/2018 - 01/2015
2	Peritonitis 11/2018 - 06/2013

Drug/Important Bio-Agent (IBA)

13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 05/2012
13	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2013
12	Vasoconstrictor AgentsIBA 12/2018 - 02/2004
12	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 02/2004
11	salicylhydroxamic acid (SHAM)IBA 02/2024 - 04/2011
11	Thioacetamide (Thioacetamid)IBA 01/2018 - 01/2005
7	Endothelin-1 (Endothelin 1)IBA 11/2018 - 01/2015
5	LipidsIBA 02/2024 - 07/2008
5	BilirubinIBA 01/2024 - 07/2008
5	Indomethacin (Indometacin)FDA LinkGeneric 01/2017 - 01/2005
5	Nitric Oxide Synthase (NO Synthase)IBA 09/2009 - 06/2004
4	Alanine Transaminase (SGPT)IBA 01/2021 - 07/2008
4	TerlipressinIBA 12/2018 - 06/2004
4	Therapeutic UsesIBA 12/2017 - 09/2006
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2017 - 09/2006
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 07/2010
3	LipopolysaccharidesIBA 09/2023 - 01/2015
3	SodiumIBA 10/2022 - 11/2009
3	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2013
3	AngiotensinsIBA 04/2020 - 01/2012
3	ReninIBA 04/2020 - 11/2012
3	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2018 - 01/2014
3	AmmoniaIBA 04/2018 - 07/2008
3	Oxygen (Dioxygen)IBA 11/2017 - 04/2013
3	Methylphenidate (Ritalin)FDA LinkGeneric 01/2017 - 10/2013
3	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2017 - 10/2013
3	Protein Isoforms (Isoforms)IBA 11/2016 - 07/2006
3	Messenger RNA (mRNA)IBA 01/2014 - 06/2004
2	oxidized low density lipoproteinIBA 02/2024 - 07/2022
2	Verteporfin (Visudyne)FDA Link 02/2024 - 04/2023
2	AlbuminsIBA 01/2024 - 10/2023
2	Propranolol (Inderal)FDA LinkGeneric 12/2023 - 12/2011
2	AntioxidantsIBA 07/2022 - 09/2017
2	CholesterolIBA 07/2022 - 12/2014
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2022 - 09/2016
2	Antiviral Agents (Antivirals)IBA 01/2021 - 11/2018
2	InterferonsIBA 01/2021 - 01/2020
2	CorticosteroneIBA 04/2020 - 01/2014
2	AldosteroneIBA 04/2020 - 03/2013
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2020 - 04/2018
2	Sirolimus (Rapamycin)FDA Link 01/2020 - 04/2018
2	Caffeine (No Doz)FDA LinkGeneric 03/2019 - 05/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 07/2008
2	AndrogensIBA 12/2018 - 08/2017
2	GlucocorticoidsIBA 12/2018 - 01/2014
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2018 - 07/2008
2	Angiogenesis InhibitorsIBA 04/2018 - 09/2017

Therapy/Procedure

53	Ligation 02/2024 - 02/2002
9	Therapeutics 01/2021 - 08/2006
4	Intraperitoneal Injections 01/2015 - 01/2005
3	Fecal Microbiota Transplantation 11/2023 - 12/2021
2	Aftercare (After-Treatment) 01/2023 - 08/2006
2	Phototherapy (Light Therapy) 01/2022 - 01/2022
2	Transplantation 12/2021 - 01/2011
2	Long-Term Care 10/2020 - 07/2020